355 related articles for article (PubMed ID: 36747201)
1. Prognostic value of cardiovascular magnetic resonance T1 mapping and extracellular volume fraction in nonischemic dilated cardiomyopathy.
Cadour F; Quemeneur M; Biere L; Donal E; Bentatou Z; Eicher JC; Roubille F; Lalande A; Giorgi R; Rapacchi S; Cortaredona S; Tradi F; Bartoli A; Willoteaux S; Delahaye F; Biene SM; Mangin L; Ferrier N; Dacher JN; Bauer F; Leurent G; Lentz PA; Kovacsik H; Croisille P; Thuny F; Bernard M; Guye M; Furber A; Habib G; Jacquier A
J Cardiovasc Magn Reson; 2023 Feb; 25(1):7. PubMed ID: 36747201
[TBL] [Abstract][Full Text] [Related]
2. Comparing CMR Mapping Methods and Myocardial Patterns Toward Heart Failure Outcomes in Nonischemic Dilated Cardiomyopathy.
Vita T; Gräni C; Abbasi SA; Neilan TG; Rowin E; Kaneko K; Coelho-Filho O; Watanabe E; Mongeon FP; Farhad H; Rassi CH; Choi YL; Cheng K; Givertz MM; Blankstein R; Steigner M; Aghayev A; Jerosch-Herold M; Kwong RY
JACC Cardiovasc Imaging; 2019 Aug; 12(8 Pt 2):1659-1669. PubMed ID: 30448130
[TBL] [Abstract][Full Text] [Related]
3. T1-Mapping and Outcome in Nonischemic Cardiomyopathy: All-Cause Mortality and Heart Failure.
Puntmann VO; Carr-White G; Jabbour A; Yu CY; Gebker R; Kelle S; Hinojar R; Doltra A; Varma N; Child N; Rogers T; Suna G; Arroyo Ucar E; Goodman B; Khan S; Dabir D; Herrmann E; Zeiher AM; Nagel E;
JACC Cardiovasc Imaging; 2016 Jan; 9(1):40-50. PubMed ID: 26762873
[TBL] [Abstract][Full Text] [Related]
4. Extracellular volume fraction assessed using cardiovascular magnetic resonance can predict improvement in left ventricular ejection fraction in patients with dilated cardiomyopathy.
Inui K; Asai K; Tachi M; Yoshinaga A; Izumi Y; Kubota Y; Murai K; Tsukada YT; Amano Y; Kumita S; Shimizu W
Heart Vessels; 2018 Oct; 33(10):1195-1203. PubMed ID: 29560528
[TBL] [Abstract][Full Text] [Related]
5. Contrast-enhanced T1 mapping-based extracellular volume fraction independently predicts clinical outcome in patients with non-ischemic dilated cardiomyopathy: a prospective cohort study.
Youn JC; Hong YJ; Lee HJ; Han K; Shim CY; Hong GR; Suh YJ; Hur J; Kim YJ; Choi BW; Kang SM
Eur Radiol; 2017 Sep; 27(9):3924-3933. PubMed ID: 28439651
[TBL] [Abstract][Full Text] [Related]
6. Combination of extracellular volume fraction by cardiac magnetic resonance imaging and QRS duration for the risk stratification for patients with non-ischemic dilated cardiomyopathy.
Kodama S; Kato S; Hayakawa K; Azuma M; Kagimoto M; Iguchi K; Fukuoka M; Fukui K; Iwasawa T; Utsunomiya D; Kosuge M; Kimura K; Tamura K
Heart Vessels; 2020 Oct; 35(10):1439-1445. PubMed ID: 32417957
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of heart failure in hemodialysis-dependent end-stage renal disease patients with myocardial fibrosis quantification by extracellular volume on cardiac magnetic resonance imaging.
Xu HY; Yang ZG; Zhang Y; Peng WL; Xia CC; Li ZL; He Y; Xu R; Rao L; Peng Y; Li YM; Gao HL; Guo YK
BMC Cardiovasc Disord; 2020 Jan; 20(1):12. PubMed ID: 31924159
[TBL] [Abstract][Full Text] [Related]
8. T1 Mapping and Extracellular Volume Fraction in Dilated Cardiomyopathy: A Prognosis Study.
Li S; Zhou D; Sirajuddin A; He J; Xu J; Zhuang B; Huang J; Yin G; Fan X; Wu W; Sun X; Zhao S; Arai AE; Lu M
JACC Cardiovasc Imaging; 2022 Apr; 15(4):578-590. PubMed ID: 34538631
[TBL] [Abstract][Full Text] [Related]
9. The prognostic value of T1 mapping and late gadolinium enhancement cardiovascular magnetic resonance imaging in patients with light chain amyloidosis.
Lin L; Li X; Feng J; Shen KN; Tian Z; Sun J; Mao YY; Cao J; Jin ZY; Li J; Selvanayagam JB; Wang YN
J Cardiovasc Magn Reson; 2018 Jan; 20(1):2. PubMed ID: 29298704
[TBL] [Abstract][Full Text] [Related]
10. Early detection of myocardial fibrosis in cardiomyopathy in the absence of late enhancement: role of T1 mapping and extracellular volume analysis.
Gao Y; Wang HP; Liu MX; Gu H; Yuan XS; Biekan J; Wang XM
Eur Radiol; 2023 Mar; 33(3):1982-1991. PubMed ID: 36241919
[TBL] [Abstract][Full Text] [Related]
11. Native T1 Mapping and Extracellular Volume Mapping for the Assessment of Diffuse Myocardial Fibrosis in Dilated Cardiomyopathy.
Nakamori S; Dohi K; Ishida M; Goto Y; Imanaka-Yoshida K; Omori T; Goto I; Kumagai N; Fujimoto N; Ichikawa Y; Kitagawa K; Yamada N; Sakuma H; Ito M
JACC Cardiovasc Imaging; 2018 Jan; 11(1):48-59. PubMed ID: 28624408
[TBL] [Abstract][Full Text] [Related]
12. Long term prognostic importance of late gadolinium enhancement in first-presentation non-ischaemic dilated cardiomyopathy.
Sree Raman K; Nucifora G; Leong DP; Marx C; Shah R; Woodman RJ; Molaee P; Shirazi MG; McGavigan AD; De Pasquale CG; Selvanayagam JB
Int J Cardiol; 2019 Apr; 280():124-129. PubMed ID: 30679073
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of late gadolinium enhancement in cardiac MRI of non-ischemic dilated cardiomyopathy patients.
Behera DR; V K AK; K K NN; S S; Nair KKM; G S; T R K; Gopalakrishnan A; S H
Indian Heart J; 2020; 72(5):362-368. PubMed ID: 33189195
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of myocardial extracellular volume fraction evaluation based on cardiac magnetic resonance T1 mapping with T1 long and short in hypertrophic cardiomyopathy.
Li Y; Liu X; Yang F; Wang J; Xu Y; Fang T; Pu L; Zhou X; Han Y; Chen Y
Eur Radiol; 2021 Jul; 31(7):4557-4567. PubMed ID: 33449190
[TBL] [Abstract][Full Text] [Related]
15. Myocardial fibrosis by T1 mapping magnetic resonance imaging predicts incident cardiovascular events and all-cause mortality: the Multi-Ethnic Study of Atherosclerosis.
Marques MD; Weinberg R; Kapoor S; Ostovaneh MR; Kato Y; Liu CY; Shea S; McClelland RL; Post WS; Bluemke DA; Lima JAC; Ambale-Venkatesh B
Eur Heart J Cardiovasc Imaging; 2022 Sep; 23(10):1407-1416. PubMed ID: 35147665
[TBL] [Abstract][Full Text] [Related]
16. Incremental value of extracellular volume assessment by cardiovascular magnetic resonance imaging in risk stratifying patients with suspected myocarditis.
Gräni C; Bière L; Eichhorn C; Kaneko K; Agarwal V; Aghayev A; Steigner M; Blankstein R; Jerosch-Herold M; Kwong RY
Int J Cardiovasc Imaging; 2019 Jun; 35(6):1067-1078. PubMed ID: 30756221
[TBL] [Abstract][Full Text] [Related]
17. Myocardial fibrosis imaging based on T1-mapping and extracellular volume fraction (ECV) measurement in muscular dystrophy patients: diagnostic value compared with conventional late gadolinium enhancement (LGE) imaging.
Florian A; Ludwig A; Rösch S; Yildiz H; Sechtem U; Yilmaz A
Eur Heart J Cardiovasc Imaging; 2014 Sep; 15(9):1004-12. PubMed ID: 24686257
[TBL] [Abstract][Full Text] [Related]
18. Extracellular Volume Associates With Outcomes More Strongly Than Native or Post-Contrast Myocardial T1.
Treibel TA; Fridman Y; Bering P; Sayeed A; Maanja M; Frojdh F; Niklasson L; Olausson E; Wong TC; Kellman P; Miller CA; Moon JC; Ugander M; Schelbert EB
JACC Cardiovasc Imaging; 2020 Jan; 13(1 Pt 1):44-54. PubMed ID: 31103587
[TBL] [Abstract][Full Text] [Related]
19. Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy.
Gulati A; Jabbour A; Ismail TF; Guha K; Khwaja J; Raza S; Morarji K; Brown TD; Ismail NA; Dweck MR; Di Pietro E; Roughton M; Wage R; Daryani Y; O'Hanlon R; Sheppard MN; Alpendurada F; Lyon AR; Cook SA; Cowie MR; Assomull RG; Pennell DJ; Prasad SK
JAMA; 2013 Mar; 309(9):896-908. PubMed ID: 23462786
[TBL] [Abstract][Full Text] [Related]
20. Extracellular volume fraction by T1 mapping predicts improvement of left ventricular ejection fraction after catheter ablation in patients with non-ischemic dilated cardiomyopathy and atrial fibrillation.
Azuma M; Kato S; Sekii R; Kodama S; Kinoshita K; Suzurikawa K; Kagimoto M; Nakayama N; Iguchi K; Fukui K; Iwasawa T; Utsunomiya D; Kimura K; Tamura K
Int J Cardiovasc Imaging; 2021 Aug; 37(8):2535-2543. PubMed ID: 33725266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
